Frank G. Basile

A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma

Elizabeth O’Donnell, Jacob P. Laubach, Andrew J. Yee et al. · British Journal of Haematology · 2018 · 162 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma

Irene M. Ghobrial, Chia‐Jen Liu, Oksana Zavidij et al. · American Journal of Hematology · 2019 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Post-Traumatic Stress Disorder And Coping Among Career Professional Firefighters

Rudy V. Nydegger, Liesl A. Nydegger, Frank G. Basile · American Journal of Health Sciences (AJHS) · 2011 · 36 citations · Full text

Medicine, Psychiatry, Psychology +12

TUMOR NECROSIS FACTOR GENETIC POLYMORPHSMS CORRELATE WITH INFECTIONS AFTER LIVER TRANSPLANTATION1

Richard B. Freeman, Cam-Ly Tran, Jessica Mattoli et al. · Transplantation · 1999 · 25 citations

Life Sciences, Immunology, Infectious Diseases +17

Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVd-lite) in Transplant-Ineligible Multiple Myeloma

Elizabeth O’Donnell, Jacob P. Laubach, Andrew J. Yee et al. · Blood · 2019 · 23 citations

Medicine, Oncology, Pharmacotherapy +12